BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 21739262)

  • 1. Clinical study on the prevention of post-ERCP pancreatitis by pancreatic duct stenting.
    Pan XP; Dang T; Meng XM; Xue KC; Chang ZH; Zhang YP
    Cell Biochem Biophys; 2011 Dec; 61(3):473-9. PubMed ID: 21739262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endoscopic pancreatic duct stents reduce the incidence of post-endoscopic retrograde cholangiopancreatography pancreatitis in high-risk patients.
    Sofuni A; Maguchi H; Mukai T; Kawakami H; Irisawa A; Kubota K; Okaniwa S; Kikuyama M; Kutsumi H; Hanada K; Ueki T; Itoi T
    Clin Gastroenterol Hepatol; 2011 Oct; 9(10):851-8; quiz e110. PubMed ID: 21749851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylaxis of post-endoscopic retrograde cholangiopancreatography pancreatitis by an endoscopic pancreatic spontaneous dislodgement stent.
    Sofuni A; Maguchi H; Itoi T; Katanuma A; Hisai H; Niido T; Toyota M; Fujii T; Harada Y; Takada T
    Clin Gastroenterol Hepatol; 2007 Nov; 5(11):1339-46. PubMed ID: 17981247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylactic temporary 3F pancreatic duct stent to prevent post-ERCP pancreatitis in patients with a difficult biliary cannulation: a multicenter, prospective, randomized study.
    Lee TH; Moon JH; Choi HJ; Han SH; Cheon YK; Cho YD; Park SH; Kim SJ
    Gastrointest Endosc; 2012 Sep; 76(3):578-85. PubMed ID: 22771100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylactic pancreas stenting followed by needle-knife fistulotomy in patients with sphincter of Oddi dysfunction and difficult cannulation: new method to prevent post-ERCP pancreatitis.
    Madácsy L; Kurucsai G; Fejes R; Székely A; Székely I
    Dig Endosc; 2009 Jan; 21(1):8-13. PubMed ID: 19691794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temporary pancreatic stent to prevent post endoscopic retrograde cholangiopancreatography pancreatitis: a preliminary, single-center, randomized controlled trial.
    Tsuchiya T; Itoi T; Sofuni A; Itokawa F; Kurihara T; Ishii K; Tsuji S; Kawai T; Moriyasu F
    J Hepatobiliary Pancreat Surg; 2007; 14(3):302-7. PubMed ID: 17520207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does leaving a main pancreatic duct stent in place reduce the incidence of precut biliary sphincterotomy-associated pancreatitis? A randomized, prospective study.
    Cha SW; Leung WD; Lehman GA; Watkins JL; McHenry L; Fogel EL; Sherman S
    Gastrointest Endosc; 2013 Feb; 77(2):209-16. PubMed ID: 23084272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis by epinephrine sprayed on the papilla.
    Xu LH; Qian JB; Gu LG; Qiu JW; Ge ZM; Lu F; Wang YM; Li YM; Lu HS
    J Gastroenterol Hepatol; 2011 Jul; 26(7):1139-44. PubMed ID: 21392105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short 5Fr vs long 3Fr pancreatic stents in patients at risk for post-endoscopic retrograde cholangiopancreatography pancreatitis.
    Chahal P; Tarnasky PR; Petersen BT; Topazian MD; Levy MJ; Gostout CJ; Baron TH
    Clin Gastroenterol Hepatol; 2009 Aug; 7(8):834-9. PubMed ID: 19447196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonprevention of post-endoscopic retrograde cholangiopancreatographic pancreatitis by pancreatic stent after aspiration of pure pancreatic juice in patients with intraductal papillary mucinous neoplasms of the pancreas.
    Harada R; Kawamoto H; Fukatsu H; Kato H; Hirao K; Kurihara N; Mizuno O; Ogawa T; Ishida E; Okada H; Yamamoto K; Yamamoto H
    Pancreas; 2010 Apr; 39(3):340-4. PubMed ID: 19823100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-ERCP pancreatitis and hyperamylasemia: patient-related and operative risk factors.
    Christoforidis E; Goulimaris I; Kanellos I; Tsalis K; Demetriades C; Betsis D
    Endoscopy; 2002 Apr; 34(4):286-92. PubMed ID: 11932783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nafamostat mesylate in the prevention of post-ERCP pancreatitis and risk factors for post-ERCP pancreatitis.
    Choi CW; Kang DH; Kim GH; Eum JS; Lee SM; Song GA; Kim DU; Kim ID; Cho M
    Gastrointest Endosc; 2009 Apr; 69(4):e11-8. PubMed ID: 19327467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of diclofenac plus somatostatin in the prevention of post-ERCP pancreatitis: a randomized, double-blind, placebo-controlled trial.
    Katsinelos P; Fasoulas K; Paroutoglou G; Chatzimavroudis G; Beltsis A; Terzoudis S; Katsinelos T; Dimou E; Zavos C; Kaltsa A; Kountouras J
    Endoscopy; 2012 Jan; 44(1):53-9. PubMed ID: 22198776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppository naproxen reduces incidence and severity of post-endoscopic retrograde cholangiopancreatography pancreatitis: Randomized controlled trial.
    Mansour-Ghanaei F; Joukar F; Taherzadeh Z; Sokhanvar H; Hasandokht T
    World J Gastroenterol; 2016 Jun; 22(21):5114-21. PubMed ID: 27275104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatic stents for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis.
    Freeman ML
    Clin Gastroenterol Hepatol; 2007 Nov; 5(11):1354-65. PubMed ID: 17981248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for postendoscopic retrograde cholangiopancreatography pancreatitis: a retrospective analysis of 7,168 cases.
    Zhou W; Li Y; Zhang Q; Li X; Meng W; Zhang L; Zhang H; Zhu K; Zhu X
    Pancreatology; 2011; 11(4):399-405. PubMed ID: 21894057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transpancreatic precut papillotomy in patients with difficulty in selective biliary cannulation.
    Sakai Y; Tsuyuguchi T; Sugiyama H; Kurosawa J; Saito M; Tawada K; Mikata R; Tada M; Ishihara T; Yokosuka O
    Hepatogastroenterology; 2011; 58(112):1853-8. PubMed ID: 22024055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreatic duct stents in the prophylaxis of pancreatic damage after endoscopic retrograde cholangiopancreatography: a systematic analysis of benefits and associated risks.
    Andriulli A; Forlano R; Napolitano G; Conoscitore P; Caruso N; Pilotto A; Di Sebastiano PL; Leandro G
    Digestion; 2007; 75(2-3):156-63. PubMed ID: 17684365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urgent ERCP with pancreatic stent placement or replacement for salvage of post-ERCP pancreatitis.
    Kerdsirichairat T; Attam R; Arain M; Bakman Y; Radosevich D; Freeman M
    Endoscopy; 2014 Dec; 46(12):1085-94. PubMed ID: 25216326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopancreatography. Gabexate in digestive endoscopy--Italian Group.
    Cavallini G; Tittobello A; Frulloni L; Masci E; Mariana A; Di Francesco V
    N Engl J Med; 1996 Sep; 335(13):919-23. PubMed ID: 8786777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.